Report Detail

Other Global Ioversol Market Insights, Forecast to 2025

  • RnM2362119
  • |
  • 12 June, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Other

Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.

Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.
Global Ioversol market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ioversol.

This report researches the worldwide Ioversol market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Ioversol breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company

Ioversol Breakdown Data by Type
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Ioversol Breakdown Data by Application
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others

Ioversol Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Ioversol Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Ioversol capacity, production, value, consumption, status and forecast;
To focus on the key Ioversol manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Ioversol :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    Global Ioversol Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Ioversol Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Ioversol Market Size Growth Rate by Type
        • 1.4.2 Ioversol 34% Injectable Solution (Optiray 160)
        • 1.4.3 Ioversol 51% Injectable Solution (Optiray 240)
        • 1.4.4 Ioversol 64% Injectable Solution (Optiray 300)
        • 1.4.5 Ioversol 68% Injectable Solution (Optiray 320)
        • 1.4.6 Ioversol 74% Injectable Solution (Optiray 350)
      • 1.5 Market by Application
        • 1.5.1 Global Ioversol Market Size Growth Rate by Application
        • 1.5.2 X-ray
        • 1.5.3 CT Scan
        • 1.5.4 Brain Disorders
        • 1.5.5 Blood Vessel Disorders
        • 1.5.6 Heart Disorders
        • 1.5.7 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Ioversol Production
        • 2.1.1 Global Ioversol Revenue 2014-2025
        • 2.1.2 Global Ioversol Production 2014-2025
        • 2.1.3 Global Ioversol Capacity 2014-2025
        • 2.1.4 Global Ioversol Marketing Pricing and Trends
      • 2.2 Ioversol Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Ioversol Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Ioversol Production by Manufacturers
        • 3.1.1 Ioversol Production by Manufacturers
        • 3.1.2 Ioversol Production Market Share by Manufacturers
      • 3.2 Ioversol Revenue by Manufacturers
        • 3.2.1 Ioversol Revenue by Manufacturers (2014-2019)
        • 3.2.2 Ioversol Revenue Share by Manufacturers (2014-2019)
      • 3.3 Ioversol Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Ioversol Production by Regions

      • 4.1 Global Ioversol Production by Regions
        • 4.1.1 Global Ioversol Production Market Share by Regions
        • 4.1.2 Global Ioversol Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Ioversol Production
        • 4.2.2 United States Ioversol Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Ioversol Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Ioversol Production
        • 4.3.2 Europe Ioversol Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Ioversol Import & Export
      • 4.4 China
        • 4.4.1 China Ioversol Production
        • 4.4.2 China Ioversol Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Ioversol Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Ioversol Production
        • 4.5.2 Japan Ioversol Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Ioversol Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Ioversol Consumption by Regions

      • 5.1 Global Ioversol Consumption by Regions
        • 5.1.1 Global Ioversol Consumption by Regions
        • 5.1.2 Global Ioversol Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Ioversol Consumption by Application
        • 5.2.2 North America Ioversol Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Ioversol Consumption by Application
        • 5.3.2 Europe Ioversol Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Ioversol Consumption by Application
        • 5.4.2 Asia Pacific Ioversol Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Ioversol Consumption by Application
        • 5.5.2 Central & South America Ioversol Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Ioversol Consumption by Application
        • 5.6.2 Middle East and Africa Ioversol Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Ioversol Breakdown Dada by Type
      • 6.2 Global Ioversol Revenue by Type
      • 6.3 Ioversol Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Ioversol Breakdown Dada by Application
        • 7.2.1 Global Ioversol Consumption by Application
        • 7.2.2 Global Ioversol Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Liebel-Flarsheim Company LLC
        • 8.1.1 Liebel-Flarsheim Company LLC Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Ioversol
        • 8.1.4 Ioversol Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Guerbet
        • 8.2.1 Guerbet Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Ioversol
        • 8.2.4 Ioversol Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Jiangsu Hengrui Medicine Co
        • 8.3.1 Jiangsu Hengrui Medicine Co Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Ioversol
        • 8.3.4 Ioversol Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Mallinckrodt Pharmaceuticals
        • 8.4.1 Mallinckrodt Pharmaceuticals Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Ioversol
        • 8.4.4 Ioversol Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Ultraject
        • 8.5.1 Ultraject Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Ioversol
        • 8.5.4 Ioversol Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 China Resources Pharmaceutical (Shanghai) Co
        • 8.6.1 China Resources Pharmaceutical (Shanghai) Co Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Ioversol
        • 8.6.4 Ioversol Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 HB Ocean
        • 8.7.1 HB Ocean Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Ioversol
        • 8.7.4 Ioversol Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Novalek Pharmaceuticals Pvt. Ltd
        • 8.8.1 Novalek Pharmaceuticals Pvt. Ltd Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Ioversol
        • 8.8.4 Ioversol Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Stellence Pharmscience Pvt. Ltd
        • 8.9.1 Stellence Pharmscience Pvt. Ltd Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Ioversol
        • 8.9.4 Ioversol Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 A.S. Joshi & Company
        • 8.10.1 A.S. Joshi & Company Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Ioversol
        • 8.10.4 Ioversol Product Description
        • 8.10.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Ioversol Production and Revenue Forecast
        • 9.1.1 Global Ioversol Production Forecast 2019-2025
        • 9.1.2 Global Ioversol Revenue Forecast 2019-2025
      • 9.2 Ioversol Production and Revenue Forecast by Regions
        • 9.2.1 Global Ioversol Revenue Forecast by Regions
        • 9.2.2 Global Ioversol Production Forecast by Regions
      • 9.3 Ioversol Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Ioversol Production Forecast by Type
        • 9.4.2 Global Ioversol Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Ioversol Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Ioversol Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Ioversol Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Ioversol Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Ioversol Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Ioversol Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Ioversol Upstream Market
        • 11.1.1 Ioversol Key Raw Material
        • 11.1.2 Typical Suppliers of Key Ioversol Raw Material
        • 11.1.3 Ioversol Raw Material Market Concentration Rate
      • 11.2 Ioversol Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Ioversol Distributors
      • 11.5 Ioversol Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Summary:
        Get latest Market Research Reports on Ioversol . Industry analysis & Market Report on Ioversol is a syndicated market report, published as Global Ioversol Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ioversol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        3,108.30
        4,662.45
        6,216.60
        3,623.10
        5,434.65
        7,246.20
        597,597.00
        896,395.50
        1,195,194.00
        325,416.00
        488,124.00
        650,832.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report